B
Bull
Bull · 25%BDMD
$3.34
情景价格
$1.140
+0.041 (+3.64%)收盘时
Loading chart…
- High
- 1.170
- Open
- 1.070
- VWAP
- 1.12
- Vol
- 33.51K
- Mkt Cap
- —
- Low
- 1.058
- Amount
- 37.61K
- EV/EBITDA, TTM
- -1.58
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
AI analysis of Baird Medical Investment Holdings Ltd (BDMD)
holdBaird Medical Investment Holdings Ltd is currently not a strong buy due to its recent financial performance and technical indicators. The stock has a current price of $1.12, and the RSI is at 41.197, indicating it is nearing oversold territory but not yet a clear buy signal. Additionally, the forward P/E ratio is 11.49, which is reasonable, but the company reported a significant decline in revenue with a 52.74% drop over the past year, raising concerns about its profitability. The main risk is the projected EPS of -0.98 for FY 2025, indicating ongoing financial challenges.
估值指标
The current forward P/E ratio for Baird Medical Investment Holdings Ltd (BDMD) is 11.49, compared to its 5-year average forward P/E of 0.26.
Alphio AI Price Scenarios for BDMD
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
事件时间线
资讯
8.508-20NewsfilterBaird Medical Secures Product Registrations in Pakistan
7.508-11NASDAQ.COMBaird Medical and Alpmed Forge Strategic Partnership for IRE Technology
- 7.508-10Newsfilter
Baird Medical Partners with Alpmed for IRE Technology Development
- 8.506-29Newsfilter
Baird Medical Successfully Launches Microwave Ablation Technology in Vietnam and Argentina
- 4.506-09Newsfilter
Baird Medical Relocates Headquarters to U.S. to Drive Global Growth
BDMD FAQ — answered by Alphio AI
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.
Baird Medical Investment Holdings Ltd is currently not a strong buy due to its recent financial performance and technical indicators. The stock has a current price of $1.12, and the RSI is at 41.197, indicating it is nearing oversold territory but not yet a clear buy signal. Additionally, the forward P/E ratio is 11.49, which is reasonable, but the company reported a significant decline in revenue with a 52.74% drop over the past year, raising concerns about its profitability. The main risk is the projected EPS of -0.98 for FY 2025, indicating ongoing financial challenges.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。